A detailed history of Janney Montgomery Scott LLC transactions in Dexcom Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 23,055 shares of DXCM stock, worth $1.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,055
Previous 28,859 20.11%
Holding current value
$1.62 Million
Previous $4 Million 34.7%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$110.31 - $140.45 $640,239 - $815,171
-5,804 Reduced 20.11%
23,055 $2.61 Million
Q1 2024

May 01, 2024

SELL
$114.22 - $140.1 $344,030 - $421,981
-3,012 Reduced 9.45%
28,859 $4 Million
Q4 2023

Feb 07, 2024

SELL
$75.49 - $124.16 $324,154 - $533,143
-4,294 Reduced 11.87%
31,871 $3.95 Million
Q3 2023

Nov 08, 2023

SELL
$86.06 - $137.93 $1.85 Million - $2.97 Million
-21,505 Reduced 37.29%
36,165 $3.37 Million
Q2 2023

Jul 26, 2023

BUY
$112.47 - $130.98 $1.47 Million - $1.71 Million
13,061 Added 29.28%
57,670 $7.41 Million
Q1 2023

Apr 28, 2023

SELL
$104.0 - $122.92 $128,232 - $151,560
-1,233 Reduced 2.69%
44,609 $5.18 Million
Q4 2022

Feb 01, 2023

BUY
$84.98 - $122.67 $900,533 - $1.3 Million
10,597 Added 30.07%
45,842 $5.19 Million
Q3 2022

Oct 25, 2022

SELL
$76.35 - $94.18 $70,776 - $87,304
-927 Reduced 2.56%
35,245 $2.84 Million
Q2 2022

Aug 03, 2022

BUY
$67.99 - $132.89 $1.89 Million - $3.7 Million
27,806 Added 332.37%
36,172 $2.7 Million
Q1 2022

May 04, 2022

BUY
$94.08 - $130.2 $71,218 - $98,561
757 Added 9.95%
8,366 $4.28 Million
Q4 2021

Jan 27, 2022

BUY
$129.87 - $162.82 $45,194 - $56,661
348 Added 4.79%
7,609 $4.09 Million
Q3 2021

Oct 29, 2021

BUY
$106.71 - $143.18 $40,763 - $54,694
382 Added 5.55%
7,261 $3.97 Million
Q2 2021

Jul 26, 2021

BUY
$80.99 - $107.93 $335,217 - $446,722
4,139 Added 151.06%
6,879 $2.94 Million
Q1 2021

Apr 27, 2021

SELL
$84.79 - $104.74 $205,700 - $254,099
-2,426 Reduced 46.96%
2,740 $985,000
Q4 2020

Jan 25, 2021

SELL
$78.0 - $104.5 $994,422 - $1.33 Million
-12,749 Reduced 71.16%
5,166 $1.91 Million
Q3 2020

Nov 06, 2020

SELL
$95.51 - $112.95 $80,132 - $94,765
-839 Reduced 4.47%
17,915 $7.39 Million
Q2 2020

Jul 23, 2020

BUY
$62.68 - $105.34 $649,678 - $1.09 Million
10,365 Added 123.55%
18,754 $7.6 Million
Q1 2020

Apr 30, 2020

SELL
$47.79 - $75.63 $142,557 - $225,604
-2,983 Reduced 26.23%
8,389 $2.26 Million
Q4 2019

Jan 21, 2020

SELL
$36.62 - $57.29 $12,890 - $20,166
-352 Reduced 3.0%
11,372 $2.49 Million
Q3 2019

Oct 29, 2019

SELL
$35.53 - $43.8 $22,597 - $27,856
-636 Reduced 5.15%
11,724 $1.75 Million
Q2 2019

Jul 29, 2019

BUY
$27.84 - $38.92 $65,618 - $91,734
2,357 Added 23.56%
12,360 $1.85 Million
Q1 2019

Apr 30, 2019

BUY
$28.07 - $38.18 $118,455 - $161,119
4,220 Added 72.97%
10,003 $1.19 Million
Q4 2018

Feb 01, 2019

BUY
$26.99 - $37.37 $39,702 - $54,971
1,471 Added 34.11%
5,783 $693,000
Q3 2018

Nov 05, 2018

SELL
$23.35 - $36.72 $1,004 - $1,578
-43 Reduced 0.99%
4,312 $617,000
Q2 2018

Jul 24, 2018

SELL
$17.54 - $25.22 $8,682 - $12,483
-495 Reduced 10.21%
4,355 $414,000
Q1 2018

Apr 19, 2018

BUY
$13.06 - $18.54 $5,224 - $7,416
400 Added 8.99%
4,850 $360,000
Q4 2017

Feb 14, 2018

BUY
$11.12 - $15.38 $49,484 - $68,441
4,450
4,450 $255,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.